20 November 2023
Pharmaceutics | Seeking Cooperation with Academic Conferences

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
Pharmaceutics (ISSN: 1999-4923) released its inaugural issue in 2009 and is now published monthly through MDPI. Over the years, Pharmaceutics has aimed to provide a professional publishing service to the scientific community, has strived toward the effective dissemination of high-caliber scientific work, and has evolved into a scholarly outlet. In 2013, Pharmaceutics joined PubMed, followed by inclusion in the Science Citation Index Expanded (SCIE), Web of Science, and Scopus (Elsevier) in 2017, achieving an Impact Factor of 5.4 in 2022, with a 5-Year Impact Factor of 6.0. Pharmaceutics’ CiteScore (Scopus) for 2022 reached 6.9, which equals a ranking of 50/278 (Q1) in the “Pharmacology & Pharmacy” category.
Pharmaceutics has forged affiliations with esteemed organizations, including the Academy of Pharmaceutical Sciences (APS), the Korean Society of Pharmaceutical Sciences and Technology (KSPST), the Pharmaceutical Solid State Research Cluster (PSSRC), and the Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG). Committed to supporting the scientific community, Pharmaceutics has cooperated with various academic conferences.
For inquiries or to express your interest in collaboration, please contact the Pharmaceutics Editorial Office at pharmaceutics@mdpi.com.